Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antianaphylaxis(antihistamines) and antidotes > Linagliptin

Linagliptin

Inquiry
  Post Date: Oct 13,2013
  Expiry Date: Oct 13,2014
  Detailed Description: Cas No. :668270-12-0 Linagliptin is an Inhibitors of dipeptidyl peptidase 4, it is a member of the “Gliptin” class of oral hypoglycemics that block DPP-4. They can be used to treat diabetes mellitus type 2.
Linagliptin was FDA approved in 2011.

  CAS Registry Number:

668270-12-0
  Synonyms: ;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione;1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;
  Molecular Formula: C25H28N8O2
  Molecular Weight: 472.5422
  Molecular Structure: 668270-12-0 Linagliptin

  Company: Stereokem     [ United States ]        
  Contact: Sundar Venkataraman
  Tel: +1-415-290-0331
  Fax:
  Email: Sundar@stereokem.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.